子宫内膜异位症女性的焦虑与抑郁:不同生育情境下的比较研究
在大学医院开展观察性队列研究,纳入2023年11月至2024年5月接受卵巢刺激和取卵的324名女性,比较子宫内膜异位症与无病对照的焦虑抑郁患病率。IVF/ICSI人群中子宫内膜异位症组抑郁显著更常见(5.5% vs 0.8%),FP人群无显著差异;严重深部性交痛独立关联焦虑和/或抑郁(调整OR 2.7,95%CI 1.1-7.2)。
要点
- IVF/ICSI人群中子宫内膜异位症组抑郁患病率5.5%,显著高于对照0.8%。
- FP人群中子宫内膜异位症组与对照的焦虑抑郁无显著差异。
- 严重深部性交痛独立关联焦虑和/或抑郁(调整OR 2.7,95%CI 1.1-7.2)。
核心结论
- 在接受IVF/ICSI的患者中,子宫内膜异位症女性抑郁显著更常见,而FP人群中未观察到显著差异。
- 作者认为这些发现强调应将心理支持整合到子宫内膜异位症女性的辅助生殖技术管理中,尤其是存在严重疼痛和/或不孕者。
研究设计与样本
- 观察性队列研究,在大学医院研究中心的 conducted。
- 纳入2023年11月至2024年5月接受卵巢刺激和取卵用于IVF/ICSI或非肿瘤性FP的女性,共324名。
- 分析两个人群:正在组建家庭而接受IVF/ICSI的不孕女性,以及接受卵母细胞玻璃化冷冻用于FP的女性。
- 根据影像学(经阴道超声和/或磁共振成像)将参与者分为子宫内膜异位症(暴露)或无病(非暴露)。
- 所有患者在取卵日完成55项问卷,包括经验证的医院焦虑抑郁量表(HADS)。
主要发现
- 共纳入324名女性:196名IVF/ICSI患者(73例子宫内膜异位症,123例对照)和128名FP患者(38例子宫内膜异位症,90例对照)。
- 总体111/324(34.3%)患有子宫内膜异位症。
- 两个人群中子宫内膜异位症女性的焦虑患病率均更高,但未达统计学显著。
- 在IVF/ICSI患者中,子宫内膜异位症组抑郁显著更常见(5.5% vs 0.8%)。
- 在FP人群中,子宫内膜异位症女性更常报告既往心理支持(21.1% vs 4.4%)和精神药物使用(13.2% vs 2.2%)。
关键数值与推荐
- 焦虑和抑郁定义为HADS-A或HADS-D评分≥11。
临床怎么用
- 作者认为应将心理支持整合到子宫内膜异位症女性的辅助生殖技术管理中,尤其是存在严重疼痛和/或不孕者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the prevalence of anxiety and depression in women with endometriosis undergoing ovarian stimulation and oocyte retrieval for in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) or fertility preservation (FP) compared with women without endometriosis. DESIGN: Observational cohort study conducted in a university hospital-based research center. SUBJECTS: Women who underwent ovarian stimulation and oocyte retrieval between November 2023 and May 2024 for IVF/ICSI or nononcological FP. Two populations were analyzed: (i) infertile women undergoing IVF/ICSI as part of a current family-building project, and (ii) women undergoing oocyte vitrification for FP. EXPOSURE: Participants were classified as endometriosis (exposed) or disease-free (unexposed) based on imaging (transvaginal ultrasound and/or magnetic resonance imaging). All patients completed a 55-item questionnaire, including the validated Hospital Anxiety and Depression Scale (HADS), on the day of oocyte retrieval. MAIN OUTCOME MEASURES: Prevalence of anxiety and depression, defined as a HADS-A or HADS-D score ≥11. RESULTS: The study included 324 women: 196 IVF/ICSI patients (73 with endometriosis and 123 controls) and 128 FP patients (38 with endometriosis and 90 controls). Overall, 111/324 (34.3%) had endometriosis. Anxiety prevalence was higher in women with endometriosis in both populations, but did not reach significance. In patients undergoing IVF/ICSI, depression was significantly more frequent in those with endometriosis vs. controls (5.5% vs. 0.8%). In the FP population, women with endometriosis more often reported prior psychological support (21.1% vs. 4.4%) and psychotropic use (13.2% vs. 2.2%). Multivariate analysis identified severe deep dyspareunia as a factor independently associated with anxiety and/or depression (adjusted odds ratio 2.7; 95% confidence interval, 1.1-7.2). CONCLUSION: Among patients undergoing IVF/ICSI, depression was significantly more prevalent in women with endometriosis, whereas no significant difference was observed in the FP population. These findings underscore the importance of integrating psychological support into assisted reproductive technology management for women with endometriosis, particularly those experiencing severe pain and/or infertility.
引用
- Bourdon M, Bolac L, Cervantes C, et al. Anxiety and depression in women with endometriosis: a comparative study across fertility contexts. Fertil Steril. 2025. PMID: 41419108. doi:10.1016/j.fertnstert.2025.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。